Exclusive special offer and discount title banner vector image

NORTH AMERICA COUGH SYRUP MARKET FORECAST 2023-2032

SCOPE OF THE REPORT

North America Cough Syrup Market by Product Type (Cough Suppressants, Combination Medicines, Expectorants) Market by Age Group (Adults, Adolescents, Pediatric) Market by Distribution Channel (Retail Pharmacies, Hospital Pharmacies, E-pharmacies) by Geography


MARKET OVERVIEW

The North America cough syrup market is predicted to project a CAGR of 2.76% during the forecast period, 2023-2032, and is estimated to garner a revenue of $1397.33 million by 2032.

The cough syrup market growth in North America is attributed to the common prevalence of cough and cold during the winter and fall months. These months witness a surge in cough syrup usage as people increasingly seek relief from symptoms like congestion and coughing.

However, stringent regulatory protocols on specific cough syrup ingredients hinder the growth of the North America cough syrup market.

North America Cough Syrup Market

To Know More About This Report, Request a Free Sample Copy

The North America cough syrup market growth assessment includes the evaluation of the United States and Canada. The growing elderly population in the United States plays a significant role in driving the demand for cough syrups. As the country’s older demographic continues to expand due to advancements in healthcare and increased life expectancy, the prevalence of age-related health problems also rises. Geriatric individuals often have weakened immune systems and chronic medical conditions that make them more susceptible to respiratory illnesses like colds, bronchitis, and pneumonia. These respiratory issues frequently lead to persistent coughing, which can be particularly distressing and disruptive for older adults. According to data from the US Census Bureau, in 2020, the elderly population reached 55.8 million individuals, accounting for 16.8% of the total US population.

Furthermore, the escalating levels of pollution in the United States are undeniably contributing to a rise in respiratory ailments among its citizens. Air pollution stemming from various sources, including car emissions, industrial facilities, and the burning of fossil fuels, has become a widespread problem as industrialization and urbanization continue to expand. Exposure to pollutants like fine particulate matter (PM2.5), ozone, and various airborne toxins can have detrimental effects on respiratory health.

These pollutants have the potential to irritate the respiratory system, leading to an increased incidence of conditions such as asthma, bronchitis, and chronic obstructive pulmonary disease (COPD). Long-term exposure to air pollution has been associated with the development and exacerbation of these respiratory illnesses. Furthermore, fine particulate matter has the ability to penetrate deep into the lungs, causing inflammation and compromising lung function, especially in individuals who are vulnerable.

The North America cough syrup market segmentation includes distribution channel, product type, and age group. The age group segment includes pediatric, adolescents, and adults. 

Cough syrups are commonly used by adults, who tend to use them more frequently. As individuals age, their immune systems may weaken, rendering them more susceptible to respiratory illnesses such as the common cold, flu, or bronchitis. Consequently, adults have a higher likelihood of contracting these illnesses compared to children, which often necessitates the use of cough syrups to alleviate coughing and discomfort. Additionally, adults are frequently exposed to elevated levels of environmental contaminants, allergies, and occupational hazards, all of which can lead to respiratory irritation and coughing. For instance, in occupational settings like offices or factories, adults may encounter dust, chemicals, or pollutants, further increasing their susceptibility to coughing.

Some of the prominent players in the North America cough syrup market are Reckitt Benckiser Group PLC, Procter & Gamble, AstraZeneca Plc, Acella Pharmaceuticals, etc.

Acella Pharmaceuticals develops, distributes, and manufactures a vast range of pharmaceutical products. The company’s product portfolio includes a range of prescription and over-the-counter (OTC) drugs that address different therapeutic areas and patient demands. The company has its headquarters in Alpharetta, Georgia, the United States. 

Its product portfolio includes Brompheniramine Pseudoephedrine Dextromethorphan, which alleviates cold and cough symptoms.

REPORT SYNOPSIS

REPORT SCOPEDETAILS
Market Forecast Years2023-2032
Base Year2022
Market Historical Years2018-2022
Forecast UnitsRevenue ($Million)
Segments Analyzed
Product Type, Age Group, Distribution Channel
Countries AnalyzedThe United States and Canada
Companies AnalyzedAbbott Laboratories, Acella Pharmaceuticals, AstraZeneca Plc, Cipla Ltd, Dabur India Ltd, Glenmark Pharmaceuticals Ltd, GSK plc, Himalaya Wellness Company, Kenvue, Merck KGaA, Novartis AG, Pfizer Inc, Procter & Gamble, Reckitt Benckiser Group PLC, Sanofi

TABLE OF CONTENT

  1. RESEARCH SCOPE & METHODOLOGY
    1. STUDY OBJECTIVES
    2. METHODOLOGY
    3. ASSUMPTIONS & LIMITATIONS
  2. EXECUTIVE SUMMARY
    1. MARKET SIZE & ESTIMATES
    2. MARKET OVERVIEW
    3. SCOPE OF STUDY
    4. CRISIS SCENARIO ANALYSIS
      1. IMPACT OF COVID-19 ON COUGH SYRUP MARKET
      2. IMPACT OF THE RUSSIA-UKRAINE WAR ON COUGH SYRUP MARKET
    5. MAJOR MARKET FINDINGS
      1. PRODUCT DIVERSIFICATION IS ON THE RISE
      2. DOMINANCE OF OTC COUGH SYRUPS HAS DRIVEN ACCESSIBILITY
      3. HEALTHCARE INFORMATION AVAILABILITY ON DIGITAL PLATFORMS INFLUENCES CONSUMER CHOICES
  3. MARKET DYNAMICS
    1. KEY DRIVERS
      1. PREVALENCE OF RESPIRATORY AILMENTS
      2. RISING GERIATRIC POPULATION
      3. INNOVATIONS IN COUGH SYRUPS
    2. KEY RESTRAINTS
      1. OVER-DOSAGE CONCERNS DRIVING CONSUMERS TOWARD ALTERNATIVES
      2. STRINGENT REGULATORY PROTOCOLS
      3. INCREASING CASES OF COUGH SYRUP DEATHS
  4. KEY ANALYTICS
    1. KEY MARKET TRENDS
      1. INCREASING SELF-MEDICATION TRENDS
      2. SHIFTING CONSUMER PREFERENCE TOWARD HERBAL COUGH SYRUPS
      3. RISING POPULARITY OF E-COMMERCE CHANNELS
      4. COMPANIES ARE OFFERING SUGAR-FREE COUGH SYRUPS
      5. GROWING INCLINATION TOWARD HOMEOPATHIC COUGH SYRUPS
    2. PORTER’S FIVE FORCES ANALYSIS
      1. BUYERS POWER
      2. SUPPLIERS POWER
      3. SUBSTITUTION
      4. NEW ENTRANTS
      5. INDUSTRY RIVALRY
    3. GROWTH PROSPECT MAPPING
      1. GROWTH PROSPECT MAPPING FOR UNITED STATES
    4. VALUE CHAIN ANALYSIS
  5. MARKET BY PRODUCT TYPE
    1. COUGH SUPPRESSANTS
      1. MARKET FORECAST FIGURE
      2. SEGMENT ANALYSIS
    2. COMBINATION MEDICINES
      1. MARKET FORECAST FIGURE
      2. SEGMENT ANALYSIS
    3. EXPECTORANTS
      1. MARKET FORECAST FIGURE
      2. SEGMENT ANALYSIS
  6. MARKET BY AGE GROUP
    1. ADULTS
      1. MARKET FORECAST FIGURE
      2. SEGMENT ANALYSIS
    2. ADOLESCENTS
      1. MARKET FORECAST FIGURE
      2. SEGMENT ANALYSIS
    3. PEDIATRIC
      1. MARKET FORECAST FIGURE
      2. SEGMENT ANALYSIS
  7. MARKET BY DISTRIBUTION CHANNEL
    1. RETAIL PHARMACIES
      1. MARKET FORECAST FIGURE
      2. SEGMENT ANALYSIS
    2. HOSPITAL PHARMACIES
      1. MARKET FORECAST FIGURE
      2. SEGMENT ANALYSIS
    3. E-PHARMACIES
      1. MARKET FORECAST FIGURE
      2. SEGMENT ANALYSIS
  8. GEOGRAPHICAL ANALYSIS
    1. NORTH AMERICA
      1. MARKET SIZE & ESTIMATES
      2. NORTH AMERICA COUGH SYRUP MARKET DRIVERS
      3. NORTH AMERICA COUGH SYRUP MARKET CHALLENGES
      4. NORTH AMERICA COUGH SYRUP MARKET REGULATORY FRAMEWORK
      5. KEY PLAYERS IN NORTH AMERICA COUGH SYRUP MARKET
      6. COUNTRY ANALYSIS
        1. UNITED STATES
          1. UNITED STATES COUGH SYRUP MARKET SIZE & OPPORTUNITIES
        2. CANADA
          1. CANADA COUGH SYRUP MARKET SIZE & OPPORTUNITIES
  9. COMPETITIVE LANDSCAPE
    1. KEY STRATEGIC DEVELOPMENTS
      1. MERGERS & ACQUISITIONS
      2. PRODUCT LAUNCHES & DEVELOPMENTS
      3. PARTNERSHIPS & AGREEMENTS
      4. BUSINESS EXPANSIONS & DIVESTITURES
    2. COMPANY PROFILES
      1. ABBOTT LABORATORIES
        1. COMPANY OVERVIEW
        2. PRODUCT LIST
        3. STRENGTHS & CHALLENGES
      2. ACELLA PHARMACEUTICALS
        1. COMPANY OVERVIEW
        2. PRODUCT LIST
        3. STRENGTHS & CHALLENGES
      3. ASTRAZENECA PLC
        1. COMPANY OVERVIEW
        2. PRODUCT LIST
        3. STRENGTHS & CHALLENGES
      4. CIPLA LTD
        1. COMPANY OVERVIEW
        2. PRODUCT LIST
        3. STRENGTHS & CHALLENGES
      5. DABUR INDIA LTD
        1. COMPANY OVERVIEW
        2. PRODUCT LIST
        3. STRENGTHS & CHALLENGES
      6. GLENMARK PHARMACEUTICALS LTD
        1. COMPANY OVERVIEW
        2. PRODUCT LIST
        3. STRENGTHS & CHALLENGES
      7. GSK PLC
        1. COMPANY OVERVIEW
        2. PRODUCT LIST
        3. STRENGTHS & CHALLENGES
      8. HIMALAYA WELLNESS COMPANY
        1. COMPANY OVERVIEW
        2. PRODUCT LIST
        3. STRENGTHS & CHALLENGES
      9. KENVUE
        1. COMPANY OVERVIEW
        2. PRODUCT LIST
        3. STRENGTHS & CHALLENGES
      10. MERCK KGAA
        1. COMPANY OVERVIEW
        2. PRODUCT LIST
        3. STRENGTHS & CHALLENGES
      11. NOVARTIS AG
        1. COMPANY OVERVIEW
        2. PRODUCT LIST
        3. STRENGTHS & CHALLENGES
      12. PFIZER INC
        1. COMPANY OVERVIEW
        2. PRODUCT LIST
        3. STRENGTHS & CHALLENGES
      13. PROCTER & GAMBLE
        1. COMPANY OVERVIEW
        2. PRODUCT LIST
        3. STRENGTHS & CHALLENGES
      14. RECKITT BENCKISER GROUP PLC
        1. COMPANY OVERVIEW
        2. PRODUCT LIST
        3. STRENGTHS & CHALLENGES
      15. SANOFI
        1. COMPANY OVERVIEW
        2. PRODUCT LIST
        3. STRENGTHS & CHALLENGES

LIST OF TABLES

TABLE 1: MARKET SNAPSHOT – COUGH SYRUP MARKET

TABLE 2: NORTH AMERICA COUGH SYRUP MARKET, BY PRODUCT TYPE, HISTORICAL YEARS, 2018-2022 (IN $ MILLION)

TABLE 3: NORTH AMERICA COUGH SYRUP MARKET, BY PRODUCT TYPE, FORECAST YEARS, 2023-2032 (IN $ MILLION)

TABLE 4: NORTH AMERICA COUGH SYRUP MARKET, BY AGE GROUP, HISTORICAL YEARS, 2018-2022 (IN $ MILLION)

TABLE 5: NORTH AMERICA COUGH SYRUP MARKET, BY AGE GROUP, FORECAST YEARS, 2023-2032 (IN $ MILLION)

TABLE 6: NORTH AMERICA COUGH SYRUP MARKET, BY DISTRIBUTION CHANNEL, HISTORICAL YEARS, 2018-2022 (IN $ MILLION)

TABLE 7: NORTH AMERICA COUGH SYRUP MARKET, BY DISTRIBUTION CHANNEL, FORECAST YEARS, 2023-2032 (IN $ MILLION)

TABLE 8: NORTH AMERICA COUGH SYRUP MARKET, BY COUNTRY, HISTORICAL YEARS, 2018-2022 (IN $ MILLION)

TABLE 9: NORTH AMERICA COUGH SYRUP MARKET, BY COUNTRY, FORECAST YEARS, 2023-2032 (IN $ MILLION)

TABLE 10: NORTH AMERICA COUGH SYRUP MARKET REGULATORY FRAMEWORK

TABLE 11: KEY PLAYERS OPERATING IN NORTH AMERICA COUGH SYRUP MARKET

TABLE 12: LIST OF MERGERS & ACQUISITIONS

TABLE 13: LIST OF PRODUCT LAUNCHES & DEVELOPMENTS

TABLE 14: LIST OF PARTNERSHIPS & AGREEMENTS

TABLE 15: LIST OF BUSINESS EXPANSIONS & DIVESTITURES

LIST OF FIGURES 

FIGURE 1: KEY MARKET TRENDS

FIGURE 2: PORTER’S FIVE FORCES ANALYSIS

FIGURE 3: GROWTH PROSPECT MAPPING FOR UNITED STATES

FIGURE 4: VALUE CHAIN ANALYSIS

FIGURE 5: NORTH AMERICA COUGH SYRUP MARKET, GROWTH POTENTIAL, BY PRODUCT TYPE, IN 2022

FIGURE 6: NORTH AMERICA COUGH SYRUP MARKET, BY COUGH SUPPRESSANTS, 2023-2032 (IN $ MILLION)

FIGURE 7: NORTH AMERICA COUGH SYRUP MARKET, BY COMBINATION MEDICINES, 2023-2032 (IN $ MILLION)

FIGURE 8: NORTH AMERICA COUGH SYRUP MARKET, BY EXPECTORANTS, 2023-2032 (IN $ MILLION)

FIGURE 9: NORTH AMERICA COUGH SYRUP MARKET, GROWTH POTENTIAL, BY AGE GROUP, IN 2022

FIGURE 10: NORTH AMERICA COUGH SYRUP MARKET, BY ADULTS, 2023-2032 (IN $ MILLION)

FIGURE 11: NORTH AMERICA COUGH SYRUP MARKET, BY ADOLESCENTS, 2023-2032 (IN $ MILLION)

FIGURE 12: NORTH AMERICA COUGH SYRUP MARKET, BY PEDIATRIC, 2023-2032 (IN $ MILLION)

FIGURE 13: NORTH AMERICA COUGH SYRUP MARKET, GROWTH POTENTIAL, BY DISTRIBUTION CHANNEL, IN 2022

FIGURE 14: NORTH AMERICA COUGH SYRUP MARKET, BY RETAIL PHARMACIES, 2023-2032 (IN $ MILLION)

FIGURE 15: NORTH AMERICA COUGH SYRUP MARKET, BY HOSPITAL PHARMACIES, 2023-2032 (IN $ MILLION)

FIGURE 16: NORTH AMERICA COUGH SYRUP MARKET, BY E-PHARMACIES, 2023-2032 (IN $ MILLION)

FIGURE 17: NORTH AMERICA COUGH SYRUP MARKET, COUNTRY OUTLOOK, 2022 & 2032 (IN %)

FIGURE 18: UNITED STATES COUGH SYRUP MARKET, 2023-2032 (IN $ MILLION)

FIGURE 19: CANADA COUGH SYRUP MARKET, 2023-2032 (IN $ MILLION)

FAQ’s